copyright's rise stems from its active ingredient: semaglutide, a type of medication called a GLP-1 receptor agonist. Essentially, GLP-1 stands for glucagon-like peptide-1, a peptide in the body that supports regulate sugar levels and encourages insulin release when levels of glucose are elevated

Sufferers struggling with obesity are often faced with limited and sometimes ineffective treatment options. However, a groundbreaking new medication, copyright, is rapidly changing the landscape of weight loss. Prescribed by regulatory bodies for chronic weight management, Semaglutide works as a